Dirk Thye
Chief Medical Officer
Advisory Board
Atlanta Veterinary Eye Clinic
Romania
Biography
Dr. Thye has participated as a member of the board of directors or scientific advisory board member for a number of companies in the anti-infective area. He received his BA in Molecular Biology from UC Berkeley, his M.D. from UCLA, and completed his residency in Internal Medicine at Stanford University.Dr. Thye led the joint development committee on behalf of Forest Laboratories in partnership with AstraZeneca. Prior to joining Cerexa, Dr. Thye was a founder and Senior Vice President of Clinical Development for Peninsula Pharmaceuticals, which was established in 2001. Peninsula Pharmaceuticals developed doripenem (Doribax) for severe bacterial infections in hospitalized patients, and the company was acquired by Johnson & Johnson in 2005.
Research Interest
Molecular Biology
